Alpha 2.0
Login Register
» Authors » Sang Eun Won

Sang Eun Won

Explore the profile of Sang Eun Won including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 96
Followers 0
Related Specialties
Radiology
General Medicine
Science
Top 10 Co-Authors
Hyo Jung Park
Kyung Won Kim
Chong Hyun Suh
Nari Kim
Junhee Pyo
Youngbin Shin
Shinkyo Yoon
Sinae Kim
Mihyun Yang
Eun Sung Lee
Published In
Korean J Radiol
PLoS One
JAMA Netw Open
Sci Rep
Oncoimmunology
Affiliations
Soon will be listed here.
Recent Articles
1.
Imaging Findings of Complications of New Anticancer Drugs
Jang J, Park H, Suh C, Won S, Lee E, Kim N, et al.
Korean J Radiol . 2025 Feb; 26(2):156-168. PMID: 39898396
The anticancer drugs have evolved significantly, spanning molecular targeted therapeutics (MTTs), immune checkpoint inhibitors (ICIs), chimeric antigen receptor T-cell (CAR-T) therapy, and antibody-drug conjugates (ADCs). Complications associated with these drugs...
2.
Summary of Key Points of the Response Assessment in Neuro-Oncology (RANO) 2.0
Won S, Suh C, Kim S, Park H, Kim K
Korean J Radiol . 2024 Apr; 25(5):407-411. PMID: 38627876
No abstract available.
3.
Uncover This Tech Term: Independent Central Image Reading
Won S, Kim S, Suh C, Park H, Kim K
Korean J Radiol . 2023 Oct; 24(11):1164-1166. PMID: 37899525
No abstract available.
4.
Evolution of Radiological Treatment Response Assessments for Cancer Immunotherapy: From iRECIST to Radiomics and Artificial Intelligence
Kim N, Lee E, Won S, Yang M, Lee A, Shin Y, et al.
Korean J Radiol . 2022 Sep; 23(11):1089-1101. PMID: 36098343
Immunotherapy has revolutionized and opened a new paradigm for cancer treatment. In the era of immunotherapy and molecular targeted therapy, precision medicine has gained emphasis, and an early response assessment...
5.
Definition, Incidence, and Challenges for Assessment of Hyperprogressive Disease During Cancer Treatment With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis
Park H, Kim K, Won S, Yoon S, Chae Y, Tirumani S, et al.
JAMA Netw Open . 2021 Mar; 4(3):e211136. PMID: 33760090
Importance: Hyperprogressive disease (HPD) is a recognized pattern of rapid tumor progression during immune checkpoint inhibitor (ICI) treatment. Definitions of HPD have not been standardized, posing the risk of capturing...
6.
Impact of pseudoprogression and treatment beyond progression on outcome in patients with non-small cell lung cancer treated with immune checkpoint inhibitors
Won S, Park H, Byun S, Pyo J, Kim J, Choi C, et al.
Oncoimmunology . 2020 Sep; 9(1):1776058. PMID: 32923136
Background: Immune checkpoint inhibitors (ICI) have become an important treatment option for non-small cell lung cancer (NSCLC). We aimed to evaluate the clinical impact of pseudoprogression (PsP) and treatment beyond...
7.
Pregnancy and neonatal outcomes of women with disabilities: a nationwide population-based study in South Korea
Shin J, Cho G, Bak S, Won S, Han S, Lee S, et al.
Sci Rep . 2020 Jun; 10(1):9200. PMID: 32514114
We investigated (1) pregnancy and neonatal outcomes in women with and without disabilities, (2) time trends in deliveries, and (3) risks of pregnancy and neonatal complications among women with various...
8.
Reliable and robust method for abdominal muscle mass quantification using CT/MRI: An explorative study in healthy subjects
Park J, Gil J, Shin Y, Won S, Huh J, You M, et al.
PLoS One . 2019 Sep; 14(9):e0222042. PMID: 31536542
Background: Quantification of abdominal muscle mass by cross-sectional imaging has been increasingly used to diagnose sarcopenia; however, the technical method for quantification has not been standardized yet. We aimed to...